Ricardo M Xavier Selected Research

Ricardo M Xavier Research Topics

Disease

22	Rheumatoid Arthritis 08/2023 - 12/2008
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2021 - 11/2008
4	Infections 05/2023 - 01/2014
3	COVID-19 01/2023 - 07/2022
3	Body Weight (Weight, Body) 08/2021 - 06/2015
3	Arthritis (Polyarthritis) 03/2017 - 09/2013
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2011 - 08/2009
2	Disease Progression 07/2023 - 11/2011
2	Experimental Arthritis 08/2021 - 03/2017
2	Fibromyalgia (Fibrositis) 09/2017 - 12/2016
1	Atopic Dermatitis (Atopic Eczema) 08/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Spondylarthritis (Spinal Arthritis) 11/2022
1	Rheumatic Diseases (Rheumatism) 07/2022
1	Edema (Dropsy) 08/2021
1	Fatigue 08/2021
1	Rheumatic Fever (Acute Articular Rheumatism) 06/2021
1	Herpes Zoster 05/2021
1	Stroke (Strokes) 10/2020
1	Delayed Puberty 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 03/2017
1	Inflammation (Inflammations) 09/2015
1	Joint Diseases (Joint Disease) 10/2013
1	Mucopolysaccharidoses 10/2013
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2011
1	Atherosclerosis 09/2011
1	Hemorrhage 08/2009
1	Chronic Disease (Chronic Diseases) 01/2002

Drug/Important Bio-Agent (IBA)

8	Antirheumatic Agents (DMARD)IBA 11/2022 - 01/2014
7	Methotrexate (Mexate)FDA LinkGeneric 05/2021 - 01/2014
4	upadacitinibIBA 05/2021 - 10/2020
4	tocilizumab (atlizumab)FDA Link 01/2021 - 05/2014
4	Etanercept (Enbrel)FDA Link 01/2017 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2002
3	AntibodiesIBA 01/2017 - 08/2009
2	Janus KinasesIBA 08/2023 - 10/2020
2	Tumor Necrosis Factor InhibitorsIBA 07/2023 - 01/2017
2	Janus Kinase InhibitorsIBA 05/2023 - 10/2020
2	Abatacept (Orencia)FDA Link 01/2021 - 10/2020
2	GlucocorticoidsIBA 01/2020 - 11/2008
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2017
2	Infliximab (Remicade)FDA Link 01/2017 - 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 08/2023
1	Phosphotransferases (Kinase)IBA 08/2023
1	CytokinesIBA 08/2023
1	Rheumatoid FactorIBA 07/2023
1	Certolizumab Pegol FDA Link 07/2023
1	Antimalarials (Antimalarial Agents)IBA 05/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2022
1	golimumab FDA Link 10/2021
1	CreatineIBA 08/2021
1	CarnosineIBA 08/2021
1	Transaminases (Aminotransferases)IBA 10/2020
1	SuspensionsIBA 01/2020
1	AlkaloidsIBA 03/2017
1	AntigensIBA 03/2017
1	methylated bovine serum albumin (MBSA)IBA 03/2017
1	montanineIBA 03/2017
1	Liposomes (Liposome)IBA 09/2015
1	PhosphatidylserinesIBA 09/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2015
1	EnzymesIBA 10/2013
1	GlycosaminoglycansIBA 10/2013
1	CollagenIBA 10/2013
1	Peptide Hydrolases (Proteases)FDA Link 10/2013
1	Proteoglycans (Proteoglycan)IBA 10/2013
1	salicylhydroxamic acid (SHAM)IBA 09/2013
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2011
1	Anticardiolipin AntibodiesIBA 09/2011
1	ProlactinIBA 09/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 09/2011
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 08/2009
1	AnticoagulantsIBA 08/2009
1	Aggrecans (Aggrecan)IBA 12/2008
1	Interleukin-6 (Interleukin 6)IBA 11/2008
1	Calcium-Binding ProteinsIBA 01/2002

Therapy/Procedure

2	Therapeutics 01/2014 - 10/2013
1	Artificial Respiration (Mechanical Ventilation) 11/2022
1	Polypharmacy 06/2021
1	Activities of Daily Living (ADL) 01/2017